ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

FDA sets path for stem cell therapies – CNN

CNNFDA sets path for stem cell therapiesCNN(CNN) Just months after the US Food and Drug Administration announced efforts to crack down on stem cell clinics touting unapproved therapies, the agency now plans to help expedite the development of stem cell… Continue reading

2018-03-08 Michael Zand NEWS

Stem Cell Therapy for Multiple Sclerosis – A Pipeline Analysis | Technavio – Business Wire (press release)

Business Wire (press release)Stem Cell Therapy for Multiple Sclerosis – A Pipeline Analysis | TechnavioBusiness Wire (press release)LONDON–(BUSINESS WIRE)–Technavio, a market research company, has announced their latest report on stem cell therapy fo… Continue reading

2018-03-08 Michael Zand NEWS

Improvements Move Broad’s CRISPR-Based Diagnostic Technology Closer to Field, Clinic – GenomeWeb

Continue reading

2018-03-08 Michael Zand NEWS

Improvements Move Broad’s CRISPR-Based Diagnostic Technology Closer to Field, Clinic – GenomeWeb

Improvements Move Broad’s CRISPR-Based Diagnostic Technology Closer to Field, Clinic
GenomeWeb
NEW YORK (GenomeWeb) – Researchers in Feng Zhang’s lab at the Broad Institute have added more CRISPR enzymes to their nucleic acid detection platform, SHERLOCK, amping up its sensitivity and making it capable of even smaller quantitative measurements …

Continue reading

2018-03-08 Michael Zand NEWS

Suspect Stem Cell Treatments Touted for Knee Arthritis – Medscape

MedscapeSuspect Stem Cell Treatments Touted for Knee ArthritisMedscapeIn a previous study that Muschler was involved in, investigators conducted a systematic review of stem cell treatments for knee osteoarthritis and focal cartilage defects of the knee… Continue reading

2018-03-08 Michael Zand NEWS

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results – GlobeNewswire (press release)


GenomeWeb

Improvements Move Broad’s CRISPR-Based Diagnostic Technology Closer to Field, Clinic
GenomeWeb
NEW YORK (GenomeWeb) – Researchers in Feng Zhang’s lab at the Broad Institute have added more CRISPR enzymes to their nucleic acid detection platform, SHERLOCK, amping up its sensitivity and making it capable of even smaller quantitative measurements …

Continue reading

2018-03-08 Michael Zand NEWS

Dr. Brentjens Discusses the Goal of Armored CAR T Cells – OncLive

The Pharma LetterDr. Brentjens Discusses the Goal of Armored CAR T CellsOncLiveRenier Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses the goal of armored chimeric antigen r… Continue reading

2018-03-08 Michael Zand NEWS

Gene knockout using new CRISPR tool makes mosquitoes highly resistant to malaria parasite – Science Daily


GlobeNewswire (press release)

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
GlobeNewswire (press release)
ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today provided a business update …
UPDATE: CRISPR Therapeutics (CRSP) PT Raised to $59 at Barclays, Street HighStreetInsider.com
Crispr Therapeutics (CRSP) Now Covered by JMP SecuritiesStockNewsTimes
11.43 % to Target, Barclays Reaffirms ‘”Overweight”’ Rating on CRISPR Therapeutics (CRSP) Shares TodayKL Daily
The Ledger Gazette –StockNewsGazette –Zacks
all 44 news articles »
Continue reading

2018-03-08 Michael Zand NEWS
  • 1
  • …
  • 423
  • 424
  • 425
  • 426
  • 427
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Science Daily

Gene knockout using new CRISPR tool makes mosquitoes highly resistant to malaria parasite
Science Daily
“Our study shows that we can use this new CRISPR/Cas9 gene-editing technology to render mosquitoes malaria-resistant by removing a so-called host factor gene,” says study senior author George Dimopoulos, PhD, professor in the Bloomberg School’s …
CRISPR genome editing hurts mosquitoes’ spread of malaria | AlphrAlphr
Gene knockout using new CRISPR tool makes mosquitoes highly …Medical Xpress
CRISPR edit makes mosquitoes far less likely to pass malariaZME Science

all 4 news articles »